RecruitingNCT03825458
Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.
Sponsor
Hospices Civils de Lyon
Enrollment
3,500 participants
Start Date
Feb 25, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
The " CirB-RNA " cohort aims to create a biological collection associated with clinical and biological data from patients with hepatitis B infection. This project is part of a much larger program that aims to characterize and quantify circulating viral RNAs as a possible new biomarker of hepatitis B functional cure.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Adults patients and minor children over 6 years of age (in Lyon) with acute or chronic hepatitis B or presenting with HBsAg loss (with/without HBs seroconversion). (Co-infected patients with HDV and/or HCV and/or HIV are eligible)
- Patients requiring blood sampling for medical care at the time of the medical appointment.
- Informed patients who do not refuse to participate.
- Persons not affiliated to a social security scheme and persons receiving medical assistance from the state may be asked to participate in the study
Exclusion Criteria4
- Patients participating at the time of the inclusion to an interventional trial evaluating a drug likely to interfere with this study.
- Persons deprived of their liberty by a judicial or administrative decision
- Adults who are subject to a legal protection measure
- Children less than 6 years old (in Lyon)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERBlood sampling
Blood sampling at each clinical follow-up visit.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03825458
Related Trials
Evaluation of Patients With Liver Disease
NCT000019711 location
Real World Assessment of People Living With Chronic Hepatitis B in Australia
NCT0491461119 locations
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
NCT039333841 location
Hep Mec Cohort in Zambia
NCT075899853 locations
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
NCT038264331 location